EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease

Ruizhi Wang iD, Bryan Maloney iD, John S Beck, Scott E Counts iD, Debomoy K Lahiri iD

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Ruizhi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Repressor Proteins, Alzheimer Disease, MicroRNAs, 3' Untranslated Regions. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIA/NIH, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Small non‐coding microRNAs (miRNAs) play essential roles in Alzheimer's disease (AD) pathogenesis. Repressor element 1‐silencing transcription factor (REST) is involved in AD, though its regulation remains unclear. METHODS We performed real‐time quantitative polymerase chain reaction (qPCR) in autopsied brain tissues to determine miR‐153‐3p and AD associations. A reporter‐based assay measured the activity of REST mRNA 3′‐untranslated region (3′‐UTR). Induced pluripotent stem cells (iPSC)‐derived neurons and human cell lines were applied to determine miR‐153‐3p regulation of endogenous proteins. RESULTS Elevation of miR‐153‐3p is associated with a reduced probability of AD, while elevated REST is associated with a greater probability of AD. The 3′‐UTR functional assay pinpointed the miR‐153‐3p binding sites. miR‐153‐3p treatment reduced REST, amyloid precursor protein (APP), and α‐synuclein (SNCA) 3′‐UTR activities and protein levels. miR‐153‐3p treatment altered REST and neuronal differentiation in iPSC‐derived neuronal stem cells. RNA‐sequencing and proteomics revealed miR‐153‐3p‐associated networks. DISCUSSION miR‐153‐3p reduces REST, APP, and SNCA expression, pointing toward its therapeutic and biomarker potential in neurodegenerative diseases. Highlights With the increased emphasis on comorbidities of Alzheimer's disease (AD) and other neurodegenerative diseases, we identified that miR‐153‐3p, as a master regulator, reduced a group of neurodegeneration related proteins: REST, amyloid precursor protein (APP) and α‐synuclein (SNCA) levels. The elevation of miR‐153‐3p levels is associated with reduced probability of AD in posterior cingulate cortex (PCC), while REST, by contrast, is associated with a greater probability of AD. miR‐153‐3p treatment alters REST protein levels and neuronal differentiation in induced pluripotent stem cells (iPSC) derived neuronal cells. RNA sequencing proteomics and interactome analysis revealed the role of miR‐153‐3p in axonal guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Repressor ProteinsAlzheimer DiseaseMicroRNAs3' Untranslated RegionsHumansCell DifferentiationNeuronsInduced Pluripotent Stem CellsCell LineBinding SitesAmyloid beta-Protein Precursoralpha-SynucleinCognitive DysfunctionRE1-Silencing Transcription Factor

Stichwörter der Autor:innen

RESTUTR activityamyloidbiomarkerdementiadrug targetnon‐coding

Substanzen

Repressor ProteinsMicroRNAs3' Untranslated RegionsAmyloid beta-Protein Precursoralpha-SynucleinRE1-Silencing Transcription FactorMIRN153 microRNA, humanSNCA protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Translational Neuroscience, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
  • Department of Family Medicine, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
  • Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Indiana University Alzheimer's Disease Research Center, Indianapolis, Indiana, USA.

ORCID-Profile: Ruizhi Wang, Bryan Maloney, Scott E Counts, Debomoy K Lahiri

Förderung

  • NIA NIH HHS
  • NIA/NIH
  • NIH HHS
  • Michigan Alzheimer's Disease Research Center
  • Indiana Alzheimer's Disease Research Center
  • National Institutes of Health

Zitieren

APA

Wang, R., Maloney, B., Beck, J. S., Counts, S. E., & Lahiri, D. K. (2025). MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70399

Vancouver

Wang R, Maloney B, Beck JS, Counts SE, Lahiri DK. MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70399

BibTeX
@article{Wang2025,
  author = {Wang, Ruizhi and Maloney, Bryan and Beck, John S and Counts, Scott E and Lahiri, Debomoy K},
  title = {MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70399}
}
Kostenlos starten →